Quick Answer
Merck & Co., Inc. reported Cash And Cash Equivalents At Carrying Value of $14.57 billion for the year ending 2025.
- Merck & Co., Inc. showed an increase of +10.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Merck & Co., Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2007 to 2025), Merck & Co., Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 173.0%.
- Historical annual values: Fiscal year 2025: $14.57 billion | Fiscal year 2024: $13.24 billion | Fiscal year 2023: $6.84 billion | Fiscal year 2022: $12.69 billion | Fiscal year 2021: $8.10 billion | Fiscal year 2020: $8.05 billion | Fiscal year 2019: $9.68 billion | Fiscal year 2018: $7.97 billion | Fiscal year 2017: $6.09 billion | Fiscal year 2016: $6.52 billion | Fiscal year 2015: $8.52 billion | Fiscal year 2014: $7.44 billion | Fiscal year 2013: $15.62 billion | Fiscal year 2012: $13.45 billion | Fiscal year 2011: $13.53 billion | Fiscal year 2010: $10.90 billion | Fiscal year 2009: $9.31 billion | Fiscal year 2008: $4.37 billion | Fiscal year 2007: $5.34 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: